“…The 31 inactive compounds consisted of compounds which do act as agonists for GPR119 at concentrations up to 10 µM, which were experimentally confirmed using the established HTRF assay Recently, Wu et al 2010 synthesized a series of piperazinylpyridine derivatives as GPR119 agonists (Wu et al, 2010). Through SAR analysis, compounds with alkylsulfonamide and isopropylcarbamate end groups displayed potent GPR119 receptor activity (Wu et al, 2010). The clustering analysis of propan-2-yl 4-( [6-[4-(propane-1-sulfonyl)piperzin-1-yl]-oxy)methylpiperidine-1-carboxylate (Wu Compound 19A) resulted in the generation of three clusters (Cluster 36, Cluster 64, and Cluster 435) of which a representative fragment from each group is shown which are responsible for the activity of this compound ( Figure 5.3).…”